肝细胞癌中的肌肉减少症:发病机制和治疗。

IF 2 4区 医学 Q3 ONCOLOGY Chemotherapy Pub Date : 2022-01-01 Epub Date: 2021-12-31 DOI:10.1159/000521741
Paolo Gallo, Marianna Silletta, Antonio De Vincentis, Federica Lo Prinzi, Francesca Terracciani, Giuseppina Di Fazio, Valentina Flagiello, Umberto Vespasiani Gentilucci, Raffaele Antonelli Incalzi, Antonio Picardi
{"title":"肝细胞癌中的肌肉减少症:发病机制和治疗。","authors":"Paolo Gallo,&nbsp;Marianna Silletta,&nbsp;Antonio De Vincentis,&nbsp;Federica Lo Prinzi,&nbsp;Francesca Terracciani,&nbsp;Giuseppina Di Fazio,&nbsp;Valentina Flagiello,&nbsp;Umberto Vespasiani Gentilucci,&nbsp;Raffaele Antonelli Incalzi,&nbsp;Antonio Picardi","doi":"10.1159/000521741","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Sarcopenia is almost constantly observed in patients with cirrhosis and hepatocellular carcinoma (HCC).</p><p><strong>Summary: </strong>Chronic liver disease represents a unique pathophysiological scenario in which sarcopenia develops and all factors involved in the pathogenesis should be taken into account for an appropriate management of the disease. No properly designed intervention studies on this topic are available and, thus, no effective strategies have been developed for clinical practice. Apart from any targeted intervention, treatment, and optimization of liver disease is crucial.</p><p><strong>Key messages: </strong>In patients with cirrhosis and HCC, nutritional support to maintain and restore nutrition status, a targeted use of branched-chain amino acids and a guided physical exercise, should all be an integral part of the multidimensional assessment and tailored interventions.</p>","PeriodicalId":10047,"journal":{"name":"Chemotherapy","volume":null,"pages":null},"PeriodicalIF":2.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"6","resultStr":"{\"title\":\"Sarcopenia in Hepatocellular Carcinoma: Pathogenesis and Management.\",\"authors\":\"Paolo Gallo,&nbsp;Marianna Silletta,&nbsp;Antonio De Vincentis,&nbsp;Federica Lo Prinzi,&nbsp;Francesca Terracciani,&nbsp;Giuseppina Di Fazio,&nbsp;Valentina Flagiello,&nbsp;Umberto Vespasiani Gentilucci,&nbsp;Raffaele Antonelli Incalzi,&nbsp;Antonio Picardi\",\"doi\":\"10.1159/000521741\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Sarcopenia is almost constantly observed in patients with cirrhosis and hepatocellular carcinoma (HCC).</p><p><strong>Summary: </strong>Chronic liver disease represents a unique pathophysiological scenario in which sarcopenia develops and all factors involved in the pathogenesis should be taken into account for an appropriate management of the disease. No properly designed intervention studies on this topic are available and, thus, no effective strategies have been developed for clinical practice. Apart from any targeted intervention, treatment, and optimization of liver disease is crucial.</p><p><strong>Key messages: </strong>In patients with cirrhosis and HCC, nutritional support to maintain and restore nutrition status, a targeted use of branched-chain amino acids and a guided physical exercise, should all be an integral part of the multidimensional assessment and tailored interventions.</p>\",\"PeriodicalId\":10047,\"journal\":{\"name\":\"Chemotherapy\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":2.0000,\"publicationDate\":\"2022-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"6\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Chemotherapy\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1159/000521741\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2021/12/31 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chemotherapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000521741","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/12/31 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 6

摘要

背景:在肝硬化和肝细胞癌(HCC)患者中几乎经常观察到肌肉减少症。摘要:慢性肝病代表了一种独特的病理生理情况,在这种情况下肌肉减少症会发展,所有涉及发病机制的因素都应该被考虑到,以适当地治疗这种疾病。目前还没有针对这一主题的适当设计的干预研究,因此,没有为临床实践开发出有效的策略。除了任何有针对性的干预,肝脏疾病的治疗和优化是至关重要的。关键信息:在肝硬化和HCC患者中,维持和恢复营养状态的营养支持,支链氨基酸的有针对性的使用和有指导的体育锻炼,都应该是多维评估和量身定制的干预措施的组成部分。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Sarcopenia in Hepatocellular Carcinoma: Pathogenesis and Management.

Background: Sarcopenia is almost constantly observed in patients with cirrhosis and hepatocellular carcinoma (HCC).

Summary: Chronic liver disease represents a unique pathophysiological scenario in which sarcopenia develops and all factors involved in the pathogenesis should be taken into account for an appropriate management of the disease. No properly designed intervention studies on this topic are available and, thus, no effective strategies have been developed for clinical practice. Apart from any targeted intervention, treatment, and optimization of liver disease is crucial.

Key messages: In patients with cirrhosis and HCC, nutritional support to maintain and restore nutrition status, a targeted use of branched-chain amino acids and a guided physical exercise, should all be an integral part of the multidimensional assessment and tailored interventions.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Chemotherapy
Chemotherapy 医学-药学
CiteScore
5.80
自引率
0.00%
发文量
34
审稿时长
6-12 weeks
期刊介绍: This journal publishes original research articles and state-of-the-art reviews on all aspects of antimicrobial and antitumor chemotherapy. The results of experimental and clinical investigations into the microbiological and pharmacologic properties of antibacterial, antiviral and antitumor compounds are major topics of publication. Papers selected for the journal offer data concerning the efficacy, toxicology, and interactions of new drugs in single or combined applications. Studies designed to determine the pharmacokinetic and pharmacodynamics properties of similar preparations and comparing their efficacy are also included. Special emphasis is given to the development of drug-resistance, an increasing problem worldwide.
期刊最新文献
Disseminated Infection Caused by Nocardia cyriacigeorgica in Immunocompromised Patient Confirmed by Whole Genome Sequencing. Downregulation of Rad51 Expression and Activity Potentiates the Cytotoxic Effect of Osimertinib in Human Non-Small Cell Lung Cancer Cells. Meta-Analysis of the Efficacy and Safety of Pembrolizumab in the Treatment of Advanced Gastric Cancer and Gastroesophageal Junction Cancer. Successful Isavuconazole Treatment for Pulmonary Mucormycosis in a Patient Intolerant to Liposomal Amphotericin B with Pharmacokinetic Insights: A Case Report. Concurrent Use of Abemaciclib and Radiotherapy in Metastatic Breast Cancer Patients: A Single-Center Experience.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1